Selective mGluR1 Antagonist EMQMCM Inhibits the Kainate-Induced Excitotoxicity in Primary Neuronal Cultures and in the Rat Hippocampus
Abundant evidence suggests that indirect inhibitory modulation of glutamatergic transmission, via metabotropic glutamatergic receptors (mGluR), may induce neuroprotection. The present study was designed to determine whether the selective antagonist of mGluR1 (3-ethyl-2-methyl-quinolin-6-yl)-(4-metho...
Saved in:
Published in | Neurotoxicity research Vol. 21; no. 4; pp. 379 - 392 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer-Verlag
01.05.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abundant evidence suggests that indirect inhibitory modulation of glutamatergic transmission, via metabotropic glutamatergic receptors (mGluR), may induce neuroprotection. The present study was designed to determine whether the selective antagonist of mGluR1 (3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxy-cyclohexyl)-methanone methanesulfonate (EMQMCM), showed neuroprotection against the kainate (KA)-induced excitotoxicity in vitro and in vivo. In in vitro studies on mouse primary cortical and hippocampal neuronal cultures, incubation with KA (150 μM) induced strong degeneration [measured as lactate dehydrogenase (LDH) efflux] and apoptosis (measured as caspase-3 activity). EMQMCM (0.1–100 μM) added 30 min to 6 h after KA, significantly attenuated the KA-induced LDH release and prevented the increase in caspase-3 activity in the cultures. Those effects were dose- and time-dependent. In in vivo studies KA (2.5 nmol/1 μl) was unilaterally injected into the rat dorsal CA1 hippocampal region. Degeneration was calculated by counting surviving neurons in the CA pyramidal layer using stereological methods. It was found that EMQMCM (5–10 nmol/1 μl) injected into the dorsal hippocampus 30 min, 1 h, or 3 h (the higher dose only) after KA significantly prevented the KA-induced neuronal degeneration. In vivo microdialysis studies in rat hippocampus showed that EMQMCM (100 μM) significantly increased γ-aminobutyric acid (GABA) and decreased glutamate release. When perfused simultaneously with KA, EMQMCM substantially increased GABA release and prevented the KA-induced glutamate release. The obtained results indicate that the mGluR1 antagonist, EMQMCM, may exert neuroprotection against excitotoxicity after delayed treatment (30 min to 6 h). The role of enhanced GABAergic transmission in the neuroprotection is postulated. |
---|---|
AbstractList | Abundant evidence suggests that indirect inhibitory modulation of glutamatergic transmission, via metabotropic glutamatergic receptors (mGluR), may induce neuroprotection. The present study was designed to determine whether the selective antagonist of mGluR1 (3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxy-cyclohexyl)-methanone methanesulfonate (EMQMCM), showed neuroprotection against the kainate (KA)-induced excitotoxicity in vitro and in vivo. In in vitro studies on mouse primary cortical and hippocampal neuronal cultures, incubation with KA (150 μM) induced strong degeneration [measured as lactate dehydrogenase (LDH) efflux] and apoptosis (measured as caspase-3 activity). EMQMCM (0.1-100 μM) added 30 min to 6 h after KA, significantly attenuated the KA-induced LDH release and prevented the increase in caspase-3 activity in the cultures. Those effects were dose- and time-dependent. In in vivo studies KA (2.5 nmol/1 μl) was unilaterally injected into the rat dorsal CA1 hippocampal region. Degeneration was calculated by counting surviving neurons in the CA pyramidal layer using stereological methods. It was found that EMQMCM (5-10 nmol/1 μl) injected into the dorsal hippocampus 30 min, 1 h, or 3 h (the higher dose only) after KA significantly prevented the KA-induced neuronal degeneration. In vivo microdialysis studies in rat hippocampus showed that EMQMCM (100 μM) significantly increased γ-aminobutyric acid (GABA) and decreased glutamate release. When perfused simultaneously with KA, EMQMCM substantially increased GABA release and prevented the KA-induced glutamate release. The obtained results indicate that the mGluR1 antagonist, EMQMCM, may exert neuroprotection against excitotoxicity after delayed treatment (30 min to 6 h). The role of enhanced GABAergic transmission in the neuroprotection is postulated. Abundant evidence suggests that indirect inhibitory modulation of glutamatergic transmission, via metabotropic glutamatergic receptors (mGluR), may induce neuroprotection. The present study was designed to determine whether the selective antagonist of mGluR1 (3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxy-cyclohexyl)-methanone methanesulfonate (EMQMCM), showed neuroprotection against the kainate (KA)-induced excitotoxicity in vitro and in vivo. In in vitro studies on mouse primary cortical and hippocampal neuronal cultures, incubation with KA (150 μM) induced strong degeneration [measured as lactate dehydrogenase (LDH) efflux] and apoptosis (measured as caspase-3 activity). EMQMCM (0.1–100 μM) added 30 min to 6 h after KA, significantly attenuated the KA-induced LDH release and prevented the increase in caspase-3 activity in the cultures. Those effects were dose- and time-dependent. In in vivo studies KA (2.5 nmol/1 μl) was unilaterally injected into the rat dorsal CA1 hippocampal region. Degeneration was calculated by counting surviving neurons in the CA pyramidal layer using stereological methods. It was found that EMQMCM (5–10 nmol/1 μl) injected into the dorsal hippocampus 30 min, 1 h, or 3 h (the higher dose only) after KA significantly prevented the KA-induced neuronal degeneration. In vivo microdialysis studies in rat hippocampus showed that EMQMCM (100 μM) significantly increased γ-aminobutyric acid (GABA) and decreased glutamate release. When perfused simultaneously with KA, EMQMCM substantially increased GABA release and prevented the KA-induced glutamate release. The obtained results indicate that the mGluR1 antagonist, EMQMCM, may exert neuroprotection against excitotoxicity after delayed treatment (30 min to 6 h). The role of enhanced GABAergic transmission in the neuroprotection is postulated. Abundant evidence suggests that indirect inhibitory modulation of glutamatergic transmission, via metabotropic glutamatergic receptors (mGluR), may induce neuroprotection. The present study was designed to determine whether the selective antagonist of mGluR1 (3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxy-cyclohexyl)-methanone methanesulfonate (EMQMCM), showed neuroprotection against the kainate (KA)-induced excitotoxicity in vitro and in vivo. In in vitro studies on mouse primary cortical and hippocampal neuronal cultures, incubation with KA (150 Delta *mM) induced strong degeneration [measured as lactate dehydrogenase (LDH) efflux] and apoptosis (measured as caspase-3 activity). EMQMCM (0.1--100 Delta *mM) added 30 min to 6 h after KA, significantly attenuated the KA-induced LDH release and prevented the increase in caspase-3 activity in the cultures. Those effects were dose- and time-dependent. In in vivo studies KA (2.5 nmol/1 Delta *ml) was unilaterally injected into the rat dorsal CA1 hippocampal region. Degeneration was calculated by counting surviving neurons in the CA pyramidal layer using stereological methods. It was found that EMQMCM (5--10 nmol/1 Delta *ml) injected into the dorsal hippocampus 30 min, 1 h, or 3 h (the higher dose only) after KA significantly prevented the KA-induced neuronal degeneration. In vivo microdialysis studies in rat hippocampus showed that EMQMCM (100 Delta *mM) significantly increased Delta *g-aminobutyric acid (GABA) and decreased glutamate release. When perfused simultaneously with KA, EMQMCM substantially increased GABA release and prevented the KA-induced glutamate release. The obtained results indicate that the mGluR1 antagonist, EMQMCM, may exert neuroprotection against excitotoxicity after delayed treatment (30 min to 6 h). The role of enhanced GABAergic transmission in the neuroprotection is postulated. |
Author | Dziubina, Anna Domin, Helena Kajta, Małgorzata Śmiałowska, Maria Zięba, Barbara Gołembiowska, Krystyna |
Author_xml | – sequence: 1 givenname: Maria surname: Śmiałowska fullname: Śmiałowska, Maria email: nfsmialo@cyf-kr.edu.pl organization: Department of Neurobiology, Institute of Pharmacology, Polish Academy of Sciences – sequence: 2 givenname: Krystyna surname: Gołembiowska fullname: Gołembiowska, Krystyna organization: Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences – sequence: 3 givenname: Małgorzata surname: Kajta fullname: Kajta, Małgorzata organization: Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences – sequence: 4 givenname: Barbara surname: Zięba fullname: Zięba, Barbara organization: Department of Neurobiology, Institute of Pharmacology, Polish Academy of Sciences – sequence: 5 givenname: Anna surname: Dziubina fullname: Dziubina, Anna organization: Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences – sequence: 6 givenname: Helena surname: Domin fullname: Domin, Helena organization: Department of Neurobiology, Institute of Pharmacology, Polish Academy of Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22144346$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1v1DAQhi1URD_gB3BBPnIJ2I5jxxekarW0K7p8FDhbjjPZdZW1U9up2j_A7yZRSgUXTmNp3nlm5OcUHfngAaHXlLyjhMj3iTLBSUEoLRRTZcGfoRPKpSjKivGj6U2YKmrO6mN0mtINIYxWQr5Ax4xRzksuTtCv79CDze4O8OGiH68pPvfZ7IJ3KeP19tt2tcUbv3eNywnnPeBPxnmTodj4drTQ4vW9dTnkcO-m-oCdx1-jO5j4gD_DGIM3PV6NfR4jJGx8OwdmzLXJ-NINQ7DmMIzpJXremT7Bq8d6hn5-XP9YXRZXXy42q_OrwnLJc6FEXbNadlZCJ-uWGyKgq1hXKiaYtaoB1VSSAiiwnaDK1KTpFLW0qjhvSFWeoQ8LdxibA7QWfI6m18Nysg7G6X873u31LtzpkimhKjIB3j4CYrgdIWV9cMlC3xsPYUyaEiqVFKyed9ElamNIKUL3tIYSPfvTiz89-dOzP82nmTd_3_c08UfYFGBLIE0tv4Oob8IYp19O_6H-Bpw5qj0 |
CitedBy_id | crossref_primary_10_1111_cns_12218 crossref_primary_10_3389_fncel_2015_00091 crossref_primary_10_1016_j_neuint_2019_104629 crossref_primary_10_1038_s41419_020_03093_6 crossref_primary_10_3390_ijms23052641 crossref_primary_10_1016_j_neuroscience_2017_09_005 crossref_primary_10_1007_s12640_013_9455_7 crossref_primary_10_1016_j_neuint_2018_02_008 crossref_primary_10_1016_j_neuro_2015_08_014 crossref_primary_10_1016_j_bbr_2023_114729 crossref_primary_10_1111_ejn_14200 crossref_primary_10_1016_j_neuro_2016_05_008 crossref_primary_10_1039_D0FO02039G crossref_primary_10_1007_s11064_016_1913_1 crossref_primary_10_1016_j_neuropharm_2016_09_003 crossref_primary_10_1096_fj_201600989R crossref_primary_10_3892_mmr_2014_2402 crossref_primary_10_1111_jnc_14546 crossref_primary_10_3390_biomedicines8110486 crossref_primary_10_1016_j_neuro_2018_04_018 |
Cites_doi | 10.1016/j.brainres.2003.11.028 10.1111/j.1365-2818.1987.tb02837.x 10.1016/S0166-2236(96)20019-0 10.1016/0028-3908(95)00077-J 10.1097/00004647-200109000-00001 10.1016/0014-2999(96)00358-5 10.1007/978-1-4612-1602-5_10 10.1016/j.euroneuro.2006.03.002 10.1016/j.neuroscience.2003.09.005 10.1016/0028-3908(94)00129-G 10.1016/S0028-3908(00)00079-4 10.1007/978-1-4615-0123-7_7 10.1016/S0304-3940(00)01483-X 10.1097/00001756-200203250-00032 10.1016/S0006-8993(01)03006-2 10.1016/j.ejphar.2005.03.028 10.1006/mcne.2001.0992 10.1016/j.brainres.2007.11.035 10.1016/j.neuropharm.2004.04.018 10.1152/jn.00625.2007 10.1016/j.devbrainres.2005.08.002 10.1016/S0028-3908(99)00097-0 10.1097/01.fbp.0000081783.35927.8f 10.1016/j.nurt.2008.10.038 10.1146/annurev.pa.21.040181.001121 10.1124/pr.108.000166 10.1016/j.neuropharm.2008.06.056 10.1016/0896-6273(88)90162-6 10.1016/j.ejphar.2008.09.026 10.1111/j.1471-4159.2008.05260.x 10.1016/j.neuroscience.2006.05.039 10.1016/j.npep.2009.02.002 10.1016/S0028-3908(98)00159-2 10.1002/jnr.490420510 10.1016/S0014-2999(03)01342-6 10.1016/S0028-3908(02)00080-1 10.1111/j.1471-4159.2004.02448.x 10.1097/00008877-200503000-00007 10.1038/sj.cdd.4400678 10.1016/j.neuint.2005.12.022 10.1111/j.1460-9568.2005.04301.x 10.1111/j.1471-4159.1983.tb00899.x 10.1046/j.1471-4159.1995.64010101.x 10.1016/j.neuroscience.2006.11.059 10.1038/376037a0 10.1038/298757a0 10.1016/j.neuroscience.2010.03.055 10.1016/S1474-4422(02)00164-3 10.1016/j.ejphar.2006.09.061 10.1146/annurev.pharmtox.37.1.205 10.1016/j.neulet.2004.03.011 10.1016/S0006-8993(01)03062-1 10.1038/sj.bjp.0706219 10.1016/j.phrs.2008.01.007 10.1006/exnr.2000.7577 10.1016/S0079-6123(08)60767-0 10.1016/0006-8993(78)90941-1 10.1016/S0028-3908(99)00102-1 10.1385/MN:31:1-3:003 10.1021/ac00125a006 10.1161/01.STR.26.3.503 10.1016/j.neuroscience.2011.06.013 10.1523/JNEUROSCI.17-06-01891.1997 10.1016/S1734-1140(10)70367-4 10.1523/JNEUROSCI.17-19-07503.1997 10.55782/ane-2000-1354 |
ContentType | Journal Article |
Copyright | The Author(s) 2011 The Author(s) 2011. This article is published with open access at Springerlink.com |
Copyright_xml | – notice: The Author(s) 2011 – notice: The Author(s) 2011. This article is published with open access at Springerlink.com |
DBID | C6C CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK 7U7 C1K 5PM |
DOI | 10.1007/s12640-011-9293-4 |
DatabaseName | Springer_OA刊 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Toxicology Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | MEDLINE Toxicology Abstracts |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1476-3524 |
EndPage | 392 |
ExternalDocumentID | 10_1007_s12640_011_9293_4 22144346 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -EM 06D 0R~ 0VX 0VY 123 1N0 203 29N 29~ 2JY 2KG 2KM 2LR 2VQ 30V 36B 4.4 406 408 40D 53G 5VS 67N 67Z 8TC 8UJ 96X AAAVM AAFGU AAHNG AAIAL AAJKR AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO AAZMS ABDBF ABDZT ABECU ABFGW ABFTV ABJNI ABJOX ABKAS ABKCH ABMQK ABPLI ABPTK ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABXPI ACBMV ACBRV ACBYP ACCUX ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACTTH ACVWB ACWMK ADHHG ADHIR ADHOK ADINQ ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFTE AEGNC AEJHL AEJRE AENEX AEOHA AEPYU AESKC AESTI AETCA AEVLU AEVTX AEXYK AFGCZ AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGMZJ AGQMX AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJWEG AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AMYQR ANMIH AOCGG AXYYD BGNMA C6C CAG COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG ESX F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FYJPI GGCAI GGRSB GJIRD GQ6 GQ7 HF~ HG6 HMJXF HRMNR HZ~ IKXTQ IWAJR IXC IXD J-C J0Z JBSCW JZLTJ KOV LLZTM M4Y M4Z MA- NPVJJ NQJWS NU0 O9- O93 O9I O9J P2P PT4 PT5 R89 R9I RNI RSV RZK S1Z S27 S3A S3B SBL SDH SHX SISQX SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 TFW TSG TUS U2A U9L UG4 UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 Z45 Z7U Z87 ZMTXR ZOVNA ~8M ~A9 AACDK AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU CGR CUY CVF ECM EIF H13 NPM ROL SJYHP TDBHL AAYXX CITATION 7TK 7U7 C1K 5PM |
ID | FETCH-LOGICAL-c474t-9688287fc7ef78d4a06ef52f39262cc9be9b571ee9ecf619a80bf91c15544b053 |
IEDL.DBID | C6C |
ISSN | 1029-8428 |
IngestDate | Tue Sep 17 21:19:19 EDT 2024 Fri Aug 16 09:03:28 EDT 2024 Thu Sep 12 18:33:52 EDT 2024 Tue Oct 15 08:26:44 EDT 2024 Sat Dec 16 12:01:49 EST 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Neuroprotection Metabotropic glutamate receptors mGlu1 antagonist Kainic acid Excitotoxicity EMQMCM |
Language | English |
License | The Author(s) 2011. This article is published with open access at Springerlink.com This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c474t-9688287fc7ef78d4a06ef52f39262cc9be9b571ee9ecf619a80bf91c15544b053 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://doi.org/10.1007/s12640-011-9293-4 |
PMID | 22144346 |
PQID | 1017976285 |
PQPubID | 23462 |
PageCount | 14 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3296950 proquest_miscellaneous_1017976285 crossref_primary_10_1007_s12640_011_9293_4 pubmed_primary_22144346 springer_journals_10_1007_s12640_011_9293_4 |
PublicationCentury | 2000 |
PublicationDate | 2012-05-01 |
PublicationDateYYYYMMDD | 2012-05-01 |
PublicationDate_xml | – month: 05 year: 2012 text: 2012-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationSubtitle | Neurodegeneration, Neuroregeneration, Neurotrophic Action, and Neuroprotection |
PublicationTitle | Neurotoxicity research |
PublicationTitleAbbrev | Neurotox Res |
PublicationTitleAlternate | Neurotox Res |
PublicationYear | 2012 |
Publisher | Springer-Verlag |
Publisher_xml | – name: Springer-Verlag |
References | Kajta, Lasoń (CR34) 2000; 60 Śmiałowska, Wierońska, Szewczyk (CR69) 2003; 55 Bruno, Battaglia, Copani, D’Onofrio, Di Iorio, De Blasi, Melchiorri, Flor, Nicoletti (CR11) 2001; 21 Olney, Ishimaru, Koliatsos, Ratan (CR56) 1999 Cozzi, Meli, Carlà, Pellicciari, Moroni, Pellegrini-Giampietro (CR18) 2002; 43 Faden, O’Leary, Fan, Bao, Mullis, Movsesyan (CR23) 2001; 167 Popoli, Pintor, Tebano, Frank, Pepponi, Nazzicone, Grieco, Pèzzola, Reggio, Minghetti, De Berardinis, Martire, Potenza, Domenici, Massotti (CR63) 2004; 89 Kajta, Lasoń, Kupiec (CR36) 2004; 123 Choi (CR13) 1988; 1 Wang, Yu, Simonyi, Sun, Sun (CR74) 2005; 31 Olney, McGeer, Olney, McGeer (CR55) 1978 Spooren, Ballard, Gasparini, Amalric, Mutel, Schreiber (CR72) 2003; 14 Kajta, Budziszewska, Lasoń (CR35) 1999; 51 Pietraszek, Sukhanov, Maciejak, Szyndler, Gravius, Wasłowska, Płaźnik, Bespalov, Danysz (CR61) 2005; 514 Bruno, Sureda, Storto, Casabona, Caruso, Knopfel, Kuhn, Nicoletti (CR8) 1997; 17 Musante, Neri, Feligioni, Puliti, Pedrazzi, Conti, Usai, Diaspro, Ravazzolo, Henley, Battaglia, Pittaluga (CR51) 2008; 55 Watkins, Evans (CR75) 1981; 21 Copani, Bruno, Barresi, Battaglia, Condorelli, Nicoletti (CR16) 1995; 64 Gołembiowska, Dziubina (CR30) 2004; 47 de Novellis, Marabese, Palazzo, Rossi, Berrino, Rodella, Bianchi, Rossi, Maione (CR20) 2003; 462 Gundersen, Jensen (CR32) 1987; 147 Rao, Hatcher, Dempsey (CR64) 2000; 293 Murotomi, Takagi, Takayanagi, Ono, Takeo, Tanonaka (CR50) 2008; 105 Pellegrini-Giampietro, Peruginelli, Meli, Cozzi, Albani-Torregrossa, Pellicciari, Moroni (CR60) 1999; 38 Makarewicz, Duszczyk, Gadamski, Danysz, Łazarewicz (CR45) 2006; 48 Flor, Battaglia, Nicoletti, Gasparini, Bruno (CR27) 2002; 513 CR46 Gołembiowska, Dziubina (CR29) 2004; 998 Shigemoto, Kinoshita, Wada, Nomura, Ohishi, Takada, Flor, Neki, Abe, Nakanishi, Mizuno (CR65) 1997; 17 Bruno, Copani, Knöpfel, Kuhn, Casabona, Dell’Albani, Condorelli, Nicoletti (CR6) 1995; 34 Conn, Pin (CR15) 1997; 37 Gasparini, Bruno, Battaglia, Lukic, Leonhardt, Inderbitzin, Laurie, Sommer, Varney, Hess, Johnson, Kuhn, Urwyler, Sauer, Portet, Schmutz, Nicoletti, Flor (CR28) 1999; 289 Ikonomidou, Turski (CR33) 2002; 1 Ossowska, Śmiałowska, Kuter, Wierońska, Zieba, Wardas, Nowak, Dabrowska, Bortel, Biedka, Schulze, Rommelspacher (CR58) 2006; 141 Bao, Williams, Faden, Tortella (CR2) 2001; 922 Ossowska, Wardas, Śmiałowska, Kuter, Lenda, Wierońska, Zieba, Nowak, Dabrowska, Bortel, Kwieciński, Wolfarth (CR57) 2005; 22 Kotlinska, Bochenski (CR41) 2008; 598 Liu, Liu, Chun, Bi, Hoe, Schreiber, Baudry (CR44) 2001; 916 Lesage, Bischoff, Van Beijsterveldt, Meert, Steckler, Ashton (CR43) 2002; 43 Nicholson, Ali, Thornberry, Vaillancourt, Ding, Gallant, Gareau, Griffin, Labelle, Lazebnik (CR52) 1995; 376 Bruno, Battaglia, Kingston, O’Neill, Catania, Di Grezia, Nicoletti (CR9) 1999; 38 Śmiałowska, Domin, Zieba, Koźniewska, Michalik, Piotrowski, Kajta (CR70) 2009; 43 Mazzone, Margaryan, Kuzhandaivel, Nasrabady, Mladinic, Nistri (CR47) 2010; 168 Paxinos, Watson (CR59) 1986 Kohara, Takahashi, Yatsugi, Tamura, Shitaka, Hayashibe, Kawabata, Okada (CR40) 2008; 1191 Pin, Duvoisin (CR62) 1995; 34 Shih, Chein, Wang, Fu (CR67) 2004; 362 Danysz, Parsons (CR19) 1998; 50 Nicoletti, Bruno, Copani, Casabona, Knöpfel (CR53) 1996; 19 Brewer (CR5) 1995; 42 Bruno, Ksiazek, Battaglia, Lukic, Leonhardt, Sauer, Gasparini, Kuhn, Nicoletti, Flor (CR10) 2000; 39 Kajta, Trotter, Lasoń, Beyer (CR37) 2005; 160 Battaglia, Bruno, Pisani, Centonie, Catania, Calabresi, Nicoletti (CR3) 2001; 17 Byrnes, Loane, Faden (CR12) 2009; 6 Ferkany, Coyle (CR24) 1983; 225 Lea, Movsesyan, Faden (CR42) 2005; 145 Shih, Wu, Chiou, Ku, Ko, Fu (CR66) 2002; 13 Kajta, Domin, Grynkiewicz, Lason (CR38) 2007; 145 Coyle (CR17) 1983; 41 Domin, Zięba, Gołembiowska, Kowalska, Dziubina, Śmiałowska (CR22) 2010; 62 Ferraguti, Crepaldi, Nicoletti (CR26) 2008; 60 Muir, Lees (CR49) 1995; 26 Choi (CR14) 1994; 100 Domin, Kajta, Smiałowska (CR21) 2006; 58 Speed, Dobrunz (CR71) 2008; 99 Knecht, Chang (CR39) 1986; 58 Ferkany, Zaczek, Coyle (CR25) 1982; 298 Bruno, Copani, Bonanno, Knoepfel, Kuhn, Roberts, Nicoletti (CR7) 1996; 310 Nicoletti, Bruno, Catania, Battaglia, Copani, Barbagallo, Ceña, Sanchez-Prieto, Spano, Pizzi (CR54) 1999; 38 Siniscalco, Giordano, Fuccio, Luongo, Ferraraccio, Rossi, de Novellis, Roth, Maione (CR68) 2008; 57 Allen, Knoblach, Faden (CR1) 2000; 7 Szydlowska, Kaminska, Baude, Parsons, Danysz (CR73) 2007; 554 Belozertseva, Kos, Popik, Danysz, Bespalov (CR4) 2007; 17 McGeer, McGeer, Singh (CR48) 1978; 139 Gravius, Pietraszek, Schäfer, Schmidt, Danysz (CR31) 2005; 16 P Popoli (9293_CR63) 2004; 89 AI Faden (9293_CR23) 2001; 167 JP Pin (9293_CR62) 1995; 34 H Domin (9293_CR21) 2006; 58 M Śmiałowska (9293_CR70) 2009; 43 M Śmiałowska (9293_CR69) 2003; 55 HJ Gundersen (9293_CR32) 1987; 147 K Ossowska (9293_CR57) 2005; 22 PJ Flor (9293_CR27) 2002; 513 G Paxinos (9293_CR59) 1986 G Battaglia (9293_CR3) 2001; 17 V Bruno (9293_CR10) 2000; 39 F Nicoletti (9293_CR53) 1996; 19 A Cozzi (9293_CR18) 2002; 43 M Kajta (9293_CR35) 1999; 51 9293_CR46 GJ Brewer (9293_CR5) 1995; 42 V Bruno (9293_CR8) 1997; 17 V Bruno (9293_CR9) 1999; 38 F Ferraguti (9293_CR26) 2008; 60 Q Wang (9293_CR74) 2005; 31 R Knecht (9293_CR39) 1986; 58 M Kajta (9293_CR37) 2005; 160 M Kajta (9293_CR38) 2007; 145 KW Muir (9293_CR49) 1995; 26 A Kohara (9293_CR40) 2008; 1191 YH Shih (9293_CR67) 2004; 362 V Bruno (9293_CR11) 2001; 21 PJ Conn (9293_CR15) 1997; 37 K Gołembiowska (9293_CR29) 2004; 998 A Gravius (9293_CR31) 2005; 16 JW Olney (9293_CR56) 1999 DW Nicholson (9293_CR52) 1995; 376 W Danysz (9293_CR19) 1998; 50 JW Allen (9293_CR1) 2000; 7 A Copani (9293_CR16) 1995; 64 V Novellis de (9293_CR20) 2003; 462 JT Coyle (9293_CR17) 1983; 41 V Bruno (9293_CR6) 1995; 34 ASJ Lesage (9293_CR43) 2002; 43 K Ossowska (9293_CR58) 2006; 141 V Bruno (9293_CR7) 1996; 310 M Kajta (9293_CR36) 2004; 123 EG McGeer (9293_CR48) 1978; 139 W Spooren (9293_CR72) 2003; 14 R Shigemoto (9293_CR65) 1997; 17 JW Ferkany (9293_CR24) 1983; 225 JW Ferkany (9293_CR25) 1982; 298 JW Olney (9293_CR55) 1978 DE Pellegrini-Giampietro (9293_CR60) 1999; 38 HE Speed (9293_CR71) 2008; 99 JC Watkins (9293_CR75) 1981; 21 K Murotomi (9293_CR50) 2008; 105 W Liu (9293_CR44) 2001; 916 M Pietraszek (9293_CR61) 2005; 514 PM Lea IV (9293_CR42) 2005; 145 AM Rao (9293_CR64) 2000; 293 WL Bao (9293_CR2) 2001; 922 GL Mazzone (9293_CR47) 2010; 168 K Szydlowska (9293_CR73) 2007; 554 DW Choi (9293_CR13) 1988; 1 DW Choi (9293_CR14) 1994; 100 F Nicoletti (9293_CR54) 1999; 38 F Gasparini (9293_CR28) 1999; 289 H Domin (9293_CR22) 2010; 62 IV Belozertseva (9293_CR4) 2007; 17 J Kotlinska (9293_CR41) 2008; 598 V Musante (9293_CR51) 2008; 55 D Makarewicz (9293_CR45) 2006; 48 KR Byrnes (9293_CR12) 2009; 6 M Kajta (9293_CR34) 2000; 60 D Siniscalco (9293_CR68) 2008; 57 C Ikonomidou (9293_CR33) 2002; 1 K Gołembiowska (9293_CR30) 2004; 47 YH Shih (9293_CR66) 2002; 13 |
References_xml | – volume: 225 start-page: 399 year: 1983 end-page: 406 ident: CR24 article-title: Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids publication-title: J Pharmacol Exp Ther contributor: fullname: Coyle – volume: 60 start-page: 365 year: 2000 end-page: 369 ident: CR34 article-title: Oestrogen effects on kainate-induced toxicity in primary cultures of rat cortical neurons publication-title: Acta Neurobiol Exp (Wars) contributor: fullname: Lasoń – volume: 998 start-page: 208 year: 2004 end-page: 217 ident: CR29 article-title: Effect of the adenosine A2A receptor antagonist 8-(3-chlorostyryl)caffeine on L-DOPA biotransformation in rat striatum publication-title: Brain Res doi: 10.1016/j.brainres.2003.11.028 contributor: fullname: Dziubina – volume: 147 start-page: 229 year: 1987 end-page: 263 ident: CR32 article-title: The efficiency of systematic sampling in stereology and its prediction publication-title: J Microsc doi: 10.1111/j.1365-2818.1987.tb02837.x contributor: fullname: Jensen – volume: 19 start-page: 267 year: 1996 end-page: 271 ident: CR53 article-title: Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? publication-title: Trends Neurosci doi: 10.1016/S0166-2236(96)20019-0 contributor: fullname: Knöpfel – volume: 34 start-page: 1089 year: 1995 end-page: 1098 ident: CR6 article-title: Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells publication-title: Neuropharmacology doi: 10.1016/0028-3908(95)00077-J contributor: fullname: Nicoletti – volume: 21 start-page: 1013 year: 2001 end-page: 1033 ident: CR11 article-title: Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs publication-title: J Cereb Blood Flow Metab doi: 10.1097/00004647-200109000-00001 contributor: fullname: Nicoletti – volume: 310 start-page: 61 year: 1996 end-page: 66 ident: CR7 article-title: Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(96)00358-5 contributor: fullname: Nicoletti – volume: 50 start-page: 597 year: 1998 end-page: 664 ident: CR19 article-title: Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications publication-title: Pharmacol Rev contributor: fullname: Parsons – start-page: 197 year: 1999 end-page: 220 ident: CR56 article-title: Excitotoxic cell death publication-title: Cell death and diseases in the nervous system doi: 10.1007/978-1-4612-1602-5_10 contributor: fullname: Ratan – volume: 17 start-page: 172 year: 2007 end-page: 179 ident: CR4 article-title: Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2006.03.002 contributor: fullname: Bespalov – volume: 123 start-page: 515 year: 2004 end-page: 526 ident: CR36 article-title: Effects of estrone on N-methyl- -aspartic acid- and staurosporine-induced changes in caspase-3-like protease activity and lactate dehydrogenase-release: time and tissue-dependent effects in neuronal cultures publication-title: Neuroscience doi: 10.1016/j.neuroscience.2003.09.005 contributor: fullname: Kupiec – volume: 34 start-page: 1 year: 1995 end-page: 26 ident: CR62 article-title: The metabotropic glutamate receptors: structure and functions publication-title: Neuropharmacology doi: 10.1016/0028-3908(94)00129-G contributor: fullname: Duvoisin – volume: 39 start-page: 2223 year: 2000 end-page: 2230 ident: CR10 article-title: Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective publication-title: Neuropharmacology doi: 10.1016/S0028-3908(00)00079-4 contributor: fullname: Flor – volume: 513 start-page: 197 year: 2002 end-page: 223 ident: CR27 article-title: Neuroprotective activity of metabotropic glutamate receptor ligands publication-title: Adv Exp Med Biol doi: 10.1007/978-1-4615-0123-7_7 contributor: fullname: Bruno – volume: 293 start-page: 1 year: 2000 end-page: 4 ident: CR64 article-title: Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil publication-title: Neurosci Lett doi: 10.1016/S0304-3940(00)01483-X contributor: fullname: Dempsey – start-page: 95 year: 1978 end-page: 112 ident: CR55 article-title: Neurotoxicity of excitatory amino acids publication-title: Kainic acid as a tool in neurobiology contributor: fullname: McGeer – volume: 13 start-page: 515 year: 2002 end-page: 519 ident: CR66 article-title: Protective effects of tetramethylpyrazine on kainate-induced excitotoxicity in hippocampal culture publication-title: Neuroreport doi: 10.1097/00001756-200203250-00032 contributor: fullname: Fu – volume: 916 start-page: 239 year: 2001 end-page: 248 ident: CR44 article-title: Kainate excitotoxicity in organotypic hippocampal slice cultures: evidence for multiple apoptotic pathways publication-title: Brain Res doi: 10.1016/S0006-8993(01)03006-2 contributor: fullname: Baudry – volume: 514 start-page: 25 year: 2005 end-page: 34 ident: CR61 article-title: Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2005.03.028 contributor: fullname: Danysz – volume: 17 start-page: 1071 year: 2001 end-page: 1083 ident: CR3 article-title: Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing GABAergic transmission publication-title: Mol Cell Neurosci doi: 10.1006/mcne.2001.0992 contributor: fullname: Nicoletti – volume: 289 start-page: 1678 year: 1999 end-page: 1687 ident: CR28 article-title: (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo publication-title: J Pharmacol Exp Ther contributor: fullname: Flor – ident: CR46 – volume: 1191 start-page: 168 year: 2008 end-page: 179 ident: CR40 article-title: Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models publication-title: Brain Res doi: 10.1016/j.brainres.2007.11.035 contributor: fullname: Okada – volume: 47 start-page: 414 year: 2004 end-page: 426 ident: CR30 article-title: Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2004.04.018 contributor: fullname: Dziubina – volume: 99 start-page: 799 year: 2008 end-page: 813 ident: CR71 article-title: Developmental decrease in short-term facilitation at Schaffer collateral synapses in hippocampus is mGluR1 sensitive publication-title: J Neurophysiol doi: 10.1152/jn.00625.2007 contributor: fullname: Dobrunz – volume: 58 start-page: 846 year: 2006 end-page: 858 ident: CR21 article-title: Neuroprotective effects of MTEP, a selective mGluR5 antagonists and neuropeptide Y on the kainate-induced toxicity in primary neuronal cultures publication-title: Pharmacol Rep contributor: fullname: Smiałowska – volume: 160 start-page: 40 year: 2005 end-page: 52 ident: CR37 article-title: Effect of NMDA on staurosporine-induced activation of caspase-3 and LDH release in mouse neocortical and hippocampal cells publication-title: Brain Res Dev Brain Res doi: 10.1016/j.devbrainres.2005.08.002 contributor: fullname: Beyer – volume: 38 start-page: 1607 year: 1999 end-page: 1619 ident: CR60 article-title: Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms publication-title: Neuropharmacology doi: 10.1016/S0028-3908(99)00097-0 contributor: fullname: Moroni – volume: 14 start-page: 257 year: 2003 end-page: 277 ident: CR72 article-title: Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders publication-title: Behav Pharmacol doi: 10.1097/01.fbp.0000081783.35927.8f contributor: fullname: Schreiber – volume: 6 start-page: 94 year: 2009 end-page: 107 ident: CR12 article-title: Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders publication-title: Neurotherapeutics doi: 10.1016/j.nurt.2008.10.038 contributor: fullname: Faden – volume: 21 start-page: 165 year: 1981 end-page: 204 ident: CR75 article-title: Excitatory amino acid transmitters publication-title: Annu Rev Pharmacol Toxicol doi: 10.1146/annurev.pa.21.040181.001121 contributor: fullname: Evans – volume: 60 start-page: 536 year: 2008 end-page: 581 ident: CR26 article-title: Metabotropic glutamate 1 receptor: current concepts and perspectives publication-title: Pharmacol Rev doi: 10.1124/pr.108.000166 contributor: fullname: Nicoletti – year: 1986 ident: CR59 publication-title: The rat brain in stereotaxic coordinates contributor: fullname: Watson – volume: 55 start-page: 474 year: 2008 end-page: 482 ident: CR51 article-title: Presynaptic mGlu1 and mGlu5 autoreceptors facilitate glutamate exocytosis from mouse cortical nerve endings publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2008.06.056 contributor: fullname: Pittaluga – volume: 1 start-page: 623 year: 1988 end-page: 634 ident: CR13 article-title: Glutamate neurotoxicity and diseases of the nervous system publication-title: Neuron doi: 10.1016/0896-6273(88)90162-6 contributor: fullname: Choi – volume: 598 start-page: 57 year: 2008 end-page: 63 ident: CR41 article-title: The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2008.09.026 contributor: fullname: Bochenski – volume: 105 start-page: 1625 year: 2008 end-page: 1634 ident: CR50 article-title: mGluR1 antagonist decreases tyrosine phosphorylation on NMDA receptor and attenuates infarct size after transient focal cerebral ischemia publication-title: J Neurochem doi: 10.1111/j.1471-4159.2008.05260.x contributor: fullname: Tanonaka – volume: 141 start-page: 2155 year: 2006 end-page: 2165 ident: CR58 article-title: Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson’s disease publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.05.039 contributor: fullname: Rommelspacher – volume: 43 start-page: 235 year: 2009 end-page: 249 ident: CR70 article-title: Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo publication-title: Neuropeptides doi: 10.1016/j.npep.2009.02.002 contributor: fullname: Kajta – volume: 38 start-page: 199 year: 1999 end-page: 207 ident: CR9 article-title: Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4-carboxyphenylglycine (LY367385): comparison with LY 357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors publication-title: Neuropharmacology doi: 10.1016/S0028-3908(98)00159-2 contributor: fullname: Nicoletti – volume: 42 start-page: 674 year: 1995 end-page: 683 ident: CR5 article-title: Serum-free B27/neurobasal medium supports differentiated growth of neurones from the striatum, substantia nigra, septum, cerebral cortex, cerebellum and dentate gyrus publication-title: J Neurosci Res doi: 10.1002/jnr.490420510 contributor: fullname: Brewer – volume: 462 start-page: 73 year: 2003 end-page: 81 ident: CR20 article-title: Group I metabotropic glutamate receptors modulate glutamate and gamma-aminobutyric acid release in the periaqueductal grey of rats publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(03)01342-6 contributor: fullname: Maione – volume: 43 start-page: 119 year: 2002 end-page: 130 ident: CR18 article-title: Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity? publication-title: Neuropharmacology doi: 10.1016/S0028-3908(02)00080-1 contributor: fullname: Pellegrini-Giampietro – volume: 89 start-page: 1479 year: 2004 end-page: 1489 ident: CR63 article-title: Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity publication-title: J Neurochem doi: 10.1111/j.1471-4159.2004.02448.x contributor: fullname: Massotti – volume: 43 start-page: 295 year: 2002 ident: CR43 article-title: Novel, centrally active mGlu1 antagonists: in vitro and in vivo pharmacology publication-title: Neuropharmacology contributor: fullname: Ashton – volume: 16 start-page: 113 year: 2005 end-page: 121 ident: CR31 article-title: Effects of mGlu1 and mGlu5 receptor antagonists on negatively reinforced learning publication-title: Behav Pharmacol doi: 10.1097/00008877-200503000-00007 contributor: fullname: Danysz – volume: 7 start-page: 470 year: 2000 end-page: 476 ident: CR1 article-title: Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4400678 contributor: fullname: Faden – volume: 48 start-page: 485 year: 2006 end-page: 490 ident: CR45 article-title: Neuroprotective potential of group I metabotropic glutamate receptor antagonists in two ischemic models publication-title: Neurochem Int doi: 10.1016/j.neuint.2005.12.022 contributor: fullname: Łazarewicz – volume: 22 start-page: 1294 year: 2005 end-page: 1304 ident: CR57 article-title: A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson’s disease? publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2005.04301.x contributor: fullname: Wolfarth – volume: 41 start-page: 1 year: 1983 end-page: 11 ident: CR17 article-title: Neurotoxic action of kainic acid publication-title: J Neurochem doi: 10.1111/j.1471-4159.1983.tb00899.x contributor: fullname: Coyle – volume: 64 start-page: 101 year: 1995 end-page: 108 ident: CR16 article-title: Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture publication-title: J Neurochem doi: 10.1046/j.1471-4159.1995.64010101.x contributor: fullname: Nicoletti – volume: 62 start-page: 1051 year: 2010 end-page: 1061 ident: CR22 article-title: Neuroprotective potential of mGluR5 antagonist MTEP: effects on kainate-induced excitotoxicity in the rat hippocampus publication-title: Pharmacol Rep contributor: fullname: Śmiałowska – volume: 145 start-page: 592 year: 2007 end-page: 604 ident: CR38 article-title: Genistein inhibits glutamate-induced apoptotic processes in primary neuronal cell cultures: an involvement of aryl hydrocarbon receptor and estrogen receptor/glycogen synthase kinase-3beta intracellular signaling pathway publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.11.059 contributor: fullname: Lason – volume: 376 start-page: 37 year: 1995 end-page: 43 ident: CR52 article-title: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis publication-title: Nature doi: 10.1038/376037a0 contributor: fullname: Lazebnik – volume: 298 start-page: 757 year: 1982 end-page: 759 ident: CR25 article-title: Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors publication-title: Nature doi: 10.1038/298757a0 contributor: fullname: Coyle – volume: 51 start-page: 531 year: 1999 end-page: 534 ident: CR35 article-title: Allopregnanolone attenuates kainate-induced toxicity in primary cortical neurons and PC12 neuronal cells publication-title: Pol J Pharmacol contributor: fullname: Lasoń – volume: 168 start-page: 451 year: 2010 end-page: 462 ident: CR47 article-title: Kainate-induced delayed onset of excitotoxicity with functional loss unrelated to the extent of neuronal damage in the in vitro spinal cord publication-title: Neuroscience doi: 10.1016/j.neuroscience.2010.03.055 contributor: fullname: Nistri – volume: 1 start-page: 383 year: 2002 end-page: 386 ident: CR33 article-title: Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? publication-title: Lancet Neurol doi: 10.1016/S1474-4422(02)00164-3 contributor: fullname: Turski – volume: 554 start-page: 18 year: 2007 end-page: 29 ident: CR73 article-title: Neuroprotective activity of selective mGlu1 and mGlu5 antagonists in vitro and in vivo publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2006.09.061 contributor: fullname: Danysz – volume: 37 start-page: 205 year: 1997 end-page: 237 ident: CR15 article-title: Pharmacology and functions of metabotropic glutamate receptors publication-title: Annu Rev Pharmacol Toxicol doi: 10.1146/annurev.pharmtox.37.1.205 contributor: fullname: Pin – volume: 362 start-page: 136 year: 2004 end-page: 140 ident: CR67 article-title: Ursolic acid protects hippocampal neurons against kainate-induced excitotoxicity in rats publication-title: Neurosci Lett doi: 10.1016/j.neulet.2004.03.011 contributor: fullname: Fu – volume: 922 start-page: 173 year: 2001 end-page: 179 ident: CR2 article-title: Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia publication-title: Brain Res doi: 10.1016/S0006-8993(01)03062-1 contributor: fullname: Tortella – volume: 145 start-page: 527 year: 2005 end-page: 534 ident: CR42 article-title: Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0706219 contributor: fullname: Faden – volume: 57 start-page: 223 year: 2008 end-page: 233 ident: CR68 article-title: Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats publication-title: Pharmacol Res doi: 10.1016/j.phrs.2008.01.007 contributor: fullname: Maione – volume: 167 start-page: 435 year: 2001 end-page: 444 ident: CR23 article-title: Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improves outcome after brain trauma publication-title: Exp Neurol doi: 10.1006/exnr.2000.7577 contributor: fullname: Movsesyan – volume: 100 start-page: 47 year: 1994 end-page: 51 ident: CR14 article-title: Glutamate receptors and the induction of excitotoxic neuronal death publication-title: Prog Brain Res doi: 10.1016/S0079-6123(08)60767-0 contributor: fullname: Choi – volume: 17 start-page: 1891 year: 1997 end-page: 1897 ident: CR8 article-title: The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling publication-title: J Neurosci contributor: fullname: Nicoletti – volume: 139 start-page: 381 year: 1978 end-page: 383 ident: CR48 article-title: Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract publication-title: Brain Res doi: 10.1016/0006-8993(78)90941-1 contributor: fullname: Singh – volume: 38 start-page: 1477 year: 1999 end-page: 1484 ident: CR54 article-title: Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection publication-title: Neuropharmacology doi: 10.1016/S0028-3908(99)00102-1 contributor: fullname: Pizzi – volume: 31 start-page: 3 year: 2005 end-page: 16 ident: CR74 article-title: Kainic acid-mediated excitotoxicity as a model for neurodegeneration publication-title: Mol Neurobiol doi: 10.1385/MN:31:1-3:003 contributor: fullname: Sun – volume: 55 start-page: 979 year: 2003 end-page: 986 ident: CR69 article-title: Neuroprotective effect of NPY on kainate neurotoxicity in the hippocampus publication-title: Pol J Pharmacol contributor: fullname: Szewczyk – volume: 17 start-page: 7503 year: 1997 end-page: 7522 ident: CR65 article-title: Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus publication-title: J Neurosci contributor: fullname: Mizuno – volume: 58 start-page: 2375 year: 1986 end-page: 2379 ident: CR39 article-title: Liquid chromatographic determination of amino acids after gas-phase hydrolysis and derivatization with (dimethylamino)azobenzenesulfonyl chloride publication-title: Anal Chem doi: 10.1021/ac00125a006 contributor: fullname: Chang – volume: 26 start-page: 503 year: 1995 end-page: 513 ident: CR49 article-title: Clinical experience with excitatory amino acid antagonist drugs publication-title: Stroke doi: 10.1161/01.STR.26.3.503 contributor: fullname: Lees – volume: 160 start-page: 40 year: 2005 ident: 9293_CR37 publication-title: Brain Res Dev Brain Res doi: 10.1016/j.devbrainres.2005.08.002 contributor: fullname: M Kajta – volume: 55 start-page: 474 year: 2008 ident: 9293_CR51 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2008.06.056 contributor: fullname: V Musante – volume: 139 start-page: 381 year: 1978 ident: 9293_CR48 publication-title: Brain Res doi: 10.1016/0006-8993(78)90941-1 contributor: fullname: EG McGeer – volume: 42 start-page: 674 year: 1995 ident: 9293_CR5 publication-title: J Neurosci Res doi: 10.1002/jnr.490420510 contributor: fullname: GJ Brewer – volume: 50 start-page: 597 year: 1998 ident: 9293_CR19 publication-title: Pharmacol Rev contributor: fullname: W Danysz – volume: 16 start-page: 113 year: 2005 ident: 9293_CR31 publication-title: Behav Pharmacol doi: 10.1097/00008877-200503000-00007 contributor: fullname: A Gravius – volume: 41 start-page: 1 year: 1983 ident: 9293_CR17 publication-title: J Neurochem doi: 10.1111/j.1471-4159.1983.tb00899.x contributor: fullname: JT Coyle – volume: 141 start-page: 2155 year: 2006 ident: 9293_CR58 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.05.039 contributor: fullname: K Ossowska – volume: 34 start-page: 1089 year: 1995 ident: 9293_CR6 publication-title: Neuropharmacology doi: 10.1016/0028-3908(95)00077-J contributor: fullname: V Bruno – volume: 55 start-page: 979 year: 2003 ident: 9293_CR69 publication-title: Pol J Pharmacol contributor: fullname: M Śmiałowska – volume: 145 start-page: 592 year: 2007 ident: 9293_CR38 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.11.059 contributor: fullname: M Kajta – volume: 43 start-page: 119 year: 2002 ident: 9293_CR18 publication-title: Neuropharmacology doi: 10.1016/S0028-3908(02)00080-1 contributor: fullname: A Cozzi – volume: 17 start-page: 1071 year: 2001 ident: 9293_CR3 publication-title: Mol Cell Neurosci doi: 10.1006/mcne.2001.0992 contributor: fullname: G Battaglia – volume: 225 start-page: 399 year: 1983 ident: 9293_CR24 publication-title: J Pharmacol Exp Ther contributor: fullname: JW Ferkany – volume: 514 start-page: 25 year: 2005 ident: 9293_CR61 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2005.03.028 contributor: fullname: M Pietraszek – volume: 298 start-page: 757 year: 1982 ident: 9293_CR25 publication-title: Nature doi: 10.1038/298757a0 contributor: fullname: JW Ferkany – volume: 293 start-page: 1 year: 2000 ident: 9293_CR64 publication-title: Neurosci Lett doi: 10.1016/S0304-3940(00)01483-X contributor: fullname: AM Rao – volume: 43 start-page: 295 year: 2002 ident: 9293_CR43 publication-title: Neuropharmacology contributor: fullname: ASJ Lesage – volume: 362 start-page: 136 year: 2004 ident: 9293_CR67 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2004.03.011 contributor: fullname: YH Shih – volume: 58 start-page: 2375 year: 1986 ident: 9293_CR39 publication-title: Anal Chem doi: 10.1021/ac00125a006 contributor: fullname: R Knecht – volume: 60 start-page: 536 year: 2008 ident: 9293_CR26 publication-title: Pharmacol Rev doi: 10.1124/pr.108.000166 contributor: fullname: F Ferraguti – volume: 105 start-page: 1625 year: 2008 ident: 9293_CR50 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2008.05260.x contributor: fullname: K Murotomi – volume: 598 start-page: 57 year: 2008 ident: 9293_CR41 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2008.09.026 contributor: fullname: J Kotlinska – volume: 38 start-page: 199 year: 1999 ident: 9293_CR9 publication-title: Neuropharmacology doi: 10.1016/S0028-3908(98)00159-2 contributor: fullname: V Bruno – volume: 6 start-page: 94 year: 2009 ident: 9293_CR12 publication-title: Neurotherapeutics doi: 10.1016/j.nurt.2008.10.038 contributor: fullname: KR Byrnes – volume: 147 start-page: 229 year: 1987 ident: 9293_CR32 publication-title: J Microsc doi: 10.1111/j.1365-2818.1987.tb02837.x contributor: fullname: HJ Gundersen – volume: 1191 start-page: 168 year: 2008 ident: 9293_CR40 publication-title: Brain Res doi: 10.1016/j.brainres.2007.11.035 contributor: fullname: A Kohara – volume: 168 start-page: 451 year: 2010 ident: 9293_CR47 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2010.03.055 contributor: fullname: GL Mazzone – volume: 123 start-page: 515 year: 2004 ident: 9293_CR36 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2003.09.005 contributor: fullname: M Kajta – volume: 48 start-page: 485 year: 2006 ident: 9293_CR45 publication-title: Neurochem Int doi: 10.1016/j.neuint.2005.12.022 contributor: fullname: D Makarewicz – volume: 554 start-page: 18 year: 2007 ident: 9293_CR73 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2006.09.061 contributor: fullname: K Szydlowska – volume-title: The rat brain in stereotaxic coordinates year: 1986 ident: 9293_CR59 contributor: fullname: G Paxinos – volume: 13 start-page: 515 year: 2002 ident: 9293_CR66 publication-title: Neuroreport doi: 10.1097/00001756-200203250-00032 contributor: fullname: YH Shih – ident: 9293_CR46 doi: 10.1016/j.neuroscience.2011.06.013 – volume: 57 start-page: 223 year: 2008 ident: 9293_CR68 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2008.01.007 contributor: fullname: D Siniscalco – volume: 26 start-page: 503 year: 1995 ident: 9293_CR49 publication-title: Stroke doi: 10.1161/01.STR.26.3.503 contributor: fullname: KW Muir – volume: 99 start-page: 799 year: 2008 ident: 9293_CR71 publication-title: J Neurophysiol doi: 10.1152/jn.00625.2007 contributor: fullname: HE Speed – volume: 51 start-page: 531 year: 1999 ident: 9293_CR35 publication-title: Pol J Pharmacol contributor: fullname: M Kajta – volume: 922 start-page: 173 year: 2001 ident: 9293_CR2 publication-title: Brain Res doi: 10.1016/S0006-8993(01)03062-1 contributor: fullname: WL Bao – volume: 64 start-page: 101 year: 1995 ident: 9293_CR16 publication-title: J Neurochem doi: 10.1046/j.1471-4159.1995.64010101.x contributor: fullname: A Copani – start-page: 197 volume-title: Cell death and diseases in the nervous system year: 1999 ident: 9293_CR56 doi: 10.1007/978-1-4612-1602-5_10 contributor: fullname: JW Olney – volume: 38 start-page: 1477 year: 1999 ident: 9293_CR54 publication-title: Neuropharmacology doi: 10.1016/S0028-3908(99)00102-1 contributor: fullname: F Nicoletti – volume: 31 start-page: 3 year: 2005 ident: 9293_CR74 publication-title: Mol Neurobiol doi: 10.1385/MN:31:1-3:003 contributor: fullname: Q Wang – volume: 37 start-page: 205 year: 1997 ident: 9293_CR15 publication-title: Annu Rev Pharmacol Toxicol doi: 10.1146/annurev.pharmtox.37.1.205 contributor: fullname: PJ Conn – volume: 145 start-page: 527 year: 2005 ident: 9293_CR42 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0706219 contributor: fullname: PM Lea IV – volume: 17 start-page: 1891 year: 1997 ident: 9293_CR8 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.17-06-01891.1997 contributor: fullname: V Bruno – volume: 916 start-page: 239 year: 2001 ident: 9293_CR44 publication-title: Brain Res doi: 10.1016/S0006-8993(01)03006-2 contributor: fullname: W Liu – volume: 1 start-page: 383 year: 2002 ident: 9293_CR33 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(02)00164-3 contributor: fullname: C Ikonomidou – volume: 14 start-page: 257 year: 2003 ident: 9293_CR72 publication-title: Behav Pharmacol doi: 10.1097/01.fbp.0000081783.35927.8f contributor: fullname: W Spooren – volume: 7 start-page: 470 year: 2000 ident: 9293_CR1 publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4400678 contributor: fullname: JW Allen – volume: 19 start-page: 267 year: 1996 ident: 9293_CR53 publication-title: Trends Neurosci doi: 10.1016/S0166-2236(96)20019-0 contributor: fullname: F Nicoletti – volume: 289 start-page: 1678 year: 1999 ident: 9293_CR28 publication-title: J Pharmacol Exp Ther contributor: fullname: F Gasparini – volume: 47 start-page: 414 year: 2004 ident: 9293_CR30 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2004.04.018 contributor: fullname: K Gołembiowska – volume: 58 start-page: 846 year: 2006 ident: 9293_CR21 publication-title: Pharmacol Rep contributor: fullname: H Domin – volume: 34 start-page: 1 year: 1995 ident: 9293_CR62 publication-title: Neuropharmacology doi: 10.1016/0028-3908(94)00129-G contributor: fullname: JP Pin – volume: 310 start-page: 61 year: 1996 ident: 9293_CR7 publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(96)00358-5 contributor: fullname: V Bruno – volume: 22 start-page: 1294 year: 2005 ident: 9293_CR57 publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2005.04301.x contributor: fullname: K Ossowska – volume: 462 start-page: 73 year: 2003 ident: 9293_CR20 publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(03)01342-6 contributor: fullname: V Novellis de – volume: 38 start-page: 1607 year: 1999 ident: 9293_CR60 publication-title: Neuropharmacology doi: 10.1016/S0028-3908(99)00097-0 contributor: fullname: DE Pellegrini-Giampietro – volume: 100 start-page: 47 year: 1994 ident: 9293_CR14 publication-title: Prog Brain Res doi: 10.1016/S0079-6123(08)60767-0 contributor: fullname: DW Choi – volume: 376 start-page: 37 year: 1995 ident: 9293_CR52 publication-title: Nature doi: 10.1038/376037a0 contributor: fullname: DW Nicholson – volume: 513 start-page: 197 year: 2002 ident: 9293_CR27 publication-title: Adv Exp Med Biol doi: 10.1007/978-1-4615-0123-7_7 contributor: fullname: PJ Flor – volume: 62 start-page: 1051 year: 2010 ident: 9293_CR22 publication-title: Pharmacol Rep doi: 10.1016/S1734-1140(10)70367-4 contributor: fullname: H Domin – volume: 89 start-page: 1479 year: 2004 ident: 9293_CR63 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2004.02448.x contributor: fullname: P Popoli – volume: 39 start-page: 2223 year: 2000 ident: 9293_CR10 publication-title: Neuropharmacology doi: 10.1016/S0028-3908(00)00079-4 contributor: fullname: V Bruno – volume: 17 start-page: 172 year: 2007 ident: 9293_CR4 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2006.03.002 contributor: fullname: IV Belozertseva – volume: 43 start-page: 235 year: 2009 ident: 9293_CR70 publication-title: Neuropeptides doi: 10.1016/j.npep.2009.02.002 contributor: fullname: M Śmiałowska – volume: 21 start-page: 1013 year: 2001 ident: 9293_CR11 publication-title: J Cereb Blood Flow Metab doi: 10.1097/00004647-200109000-00001 contributor: fullname: V Bruno – volume: 998 start-page: 208 year: 2004 ident: 9293_CR29 publication-title: Brain Res doi: 10.1016/j.brainres.2003.11.028 contributor: fullname: K Gołembiowska – volume: 167 start-page: 435 year: 2001 ident: 9293_CR23 publication-title: Exp Neurol doi: 10.1006/exnr.2000.7577 contributor: fullname: AI Faden – volume: 21 start-page: 165 year: 1981 ident: 9293_CR75 publication-title: Annu Rev Pharmacol Toxicol doi: 10.1146/annurev.pa.21.040181.001121 contributor: fullname: JC Watkins – start-page: 95 volume-title: Kainic acid as a tool in neurobiology year: 1978 ident: 9293_CR55 contributor: fullname: JW Olney – volume: 17 start-page: 7503 year: 1997 ident: 9293_CR65 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.17-19-07503.1997 contributor: fullname: R Shigemoto – volume: 1 start-page: 623 year: 1988 ident: 9293_CR13 publication-title: Neuron doi: 10.1016/0896-6273(88)90162-6 contributor: fullname: DW Choi – volume: 60 start-page: 365 year: 2000 ident: 9293_CR34 publication-title: Acta Neurobiol Exp (Wars) doi: 10.55782/ane-2000-1354 contributor: fullname: M Kajta |
SSID | ssj0021567 |
Score | 2.146487 |
Snippet | Abundant evidence suggests that indirect inhibitory modulation of glutamatergic transmission, via metabotropic glutamatergic receptors (mGluR), may induce... |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 379 |
SubjectTerms | Animals Apoptosis Apoptosis - drug effects Biomedical and Life Sciences Biomedicine Caspase 3 - metabolism Caspase-3 Cell Biology Cell culture Cerebral Cortex - drug effects Cerebral Cortex - pathology Degeneration Dose-Response Relationship, Drug Drug Interactions Enumeration Excitotoxicity gamma -Aminobutyric acid gamma-Aminobutyric Acid - metabolism Glutamatergic transmission Glutamic acid Glutamic Acid - metabolism Glutamic acid receptors (metabotropic) Hippocampus Hippocampus - drug effects Hippocampus - pathology Kainic Acid - administration & dosage Kainic Acid - antagonists & inhibitors Kainic Acid - toxicity L-Lactate dehydrogenase L-Lactate Dehydrogenase - metabolism Male Metabotropic receptors Mice Microdialysis Microinjections Nerve Degeneration - chemically induced Nerve Degeneration - pathology Neurobiology Neurochemistry Neurology Neurons Neuroprotection Neuroprotective Agents - pharmacology Neurosciences Neurotoxicity Neurotransmission Pharmacology/Toxicology Primary Cell Culture Quinolines - administration & dosage Quinolines - pharmacology Rats Rats, Wistar |
Title | Selective mGluR1 Antagonist EMQMCM Inhibits the Kainate-Induced Excitotoxicity in Primary Neuronal Cultures and in the Rat Hippocampus |
URI | https://link.springer.com/article/10.1007/s12640-011-9293-4 https://www.ncbi.nlm.nih.gov/pubmed/22144346 https://search.proquest.com/docview/1017976285 https://pubmed.ncbi.nlm.nih.gov/PMC3296950 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BKyEuiHfDozISJ1BEnDh2clyttl2ogqCwUjlFjmOrkah3RbJS-wf6u5lJsou2hQOXXGxNHp_tmcnMfAPwltdxXXPDw0w6dFBsrMPKpiZMnFRK1jrVPU9B8VnOF-LTWXo2kkVTLcyN-P2HlqPGptQpHqIiT0JxF_ZTLiNawFM53fpW6Ib0fVQomyNDk3oTwPybiF0VdMuuvJ0eeSNG2queo4fwYLQZ2WQA-RHcsf4x3CvGqPgTuP7WN7PBc4tdHP9cn3I28RRsIlJcNiu-FtOCffTnTdV0LUODj51QyVRnQ-rbYWzNZpcGN3a3vESB3RVrPPsykFCwnruDbj5Qb9qWaV_TBBJzqjs2b1YrVIcXq3X7FBZHs-_TeTj2VwiNUKILc5kR3b0zyjqV1UJH0ro0dglxCBqTVzavUsWtza1x6GjpLKpcjsCiCSIq3L3PYM8vvT0AJuh_VOy4Mi4SVuOoc1ZWnCfGpprrAN5tPnm5Gt6g_EOYTPiUiE9J-JQigDcbUEpc7BTB0N4u123Znx-Kqj4DeD6AtBUXE_lbImQAage-7QQi0t4d8c15T6idxLnM0yiA9xugy3Ent_9-yhf_Nfsl3EdTKx5SJV_BXvdrbV-jOdNVh7A_Of5xMjvsFzReF_HkNxLv8MI |
link.rule.ids | 230,315,786,790,891,27955,27956,41114,41153,41556,42183,42222,42625,51609,52144,52267 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7BVgIuvAvhaSROoFTrxHkdV9W2W7apoGylcopsx1YjaHZFEqnwA_jdzOSx1bZw6NnWOPbY88jMfAPwnudennPN3Ti06KAYT7rKBNr1bRhFYS4D2eIUpEfh7ER8Og1O-zruash2H0KSraS-LHZD3U1JVNxFle674jZsCVLwI9ia7H-bT9d-FrokbU8VyuyI0bwegpn_IrKpjq7ZmNdTJa_ES1s1tPcAFsMGuuyT7ztNrXb07yvYjjfc4UO435ulbNLdo0dwy5SP4U7aB96fwJ-vbb8cFI3sfP9Hc8zZpKR4FuHusmn6Jd1N2UF5VqiirhjalGxOVVm1cak1iDY5m15olB318gIJ1r9YUbLPHc4Fa-FBaPEO3dNUTJY5TSAyx7Jms2K1Qo17vmqqp3CyN13szty-hYOrRSRqNwljQtS3OjI2inMhx6GxgWd9ginUOlEmUUHEjUmMtujLyXisbIJ3B60coVBAbMOoXJbmOTBBv7w8yyNtx8JIHLXWhIpzX5tAcunAh4GT2arbQXaJyUwnm-HJZnSymXDg3cDrDN8TBUlkaZZNlbUiKqLCUgeedbxfk_MIX84XoQPRxq1YTyCs7s2RsjhrMbt9LwmTYOzAx4H1WS8sqv9_5YsbzX4Ld2eL9DA7PDiav4R7aNl5XWbmKxjVPxvzGq2nWr3pX8tfa1sSIA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSBUXxLsBCkbiBIq6Thw7OVbb3W4pqUqhUm-R49hqJOqNiFcqf4DfzUweWy2lB862Jo8v45nJzHxDyAdWRVXFNAtTYSFAMZEKS5PoMLZCSlGpRHU8BfmJWJzzzxfJxTDntB2r3ceUZN_TgCxNzu81ld27aXwDO44FVSwE8x6H_D55wMG36bK1YrqOuCA46aarYI1HCo72mNb8l4hNw3TL27xdNPlX5rQzSPPH5NHgSdL9Hvon5J5xT8l2PuTKn5Hf37oRN3Ca0avDH6szRvcdpqCQKpfO8q_5NKdH7rIua99ScAPpMTZSeRPiNA9tKjq71qDufnkNAv0vWjt62lNT0I7RAy_eE3KalipX4QYUc6Y8XdRNA0byqlm1z8n5fPZ9ugiHqQuh5pL7MBMpkuBbLY2VacXVRBibRDZGZkGts9JkZSKZMZnRFsIvlU5KmwHc4JjwEnT6BdlyS2d2COX4lyqyTGo74UbBqrVGlIzF2iSKqYB8HF950fRPUNzQKCM-BeBTID4FD8j7EZQCVADzGsqZ5aotulNFYi9oQF72IK3FRUgJF3MRELkB33oD0mtvrrj6sqPZjqNMZMkkIJ9GoItBv9u77_LVf-1-R7ZPD-bFl6OT49fkIfhiUV9L-YZs-Z8rswv-ji_fdt_0HxWZ-XY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Selective+mGluR1+Antagonist+EMQMCM+Inhibits+the+Kainate-Induced+Excitotoxicity+in+Primary+Neuronal+Cultures+and+in+the+Rat+Hippocampus&rft.jtitle=Neurotoxicity+research&rft.au=%C5%9Amia%C5%82owska%2C+Maria&rft.au=Go%C5%82embiowska%2C+Krystyna&rft.au=Kajta%2C+Ma%C5%82gorzata&rft.au=Zi%C4%99ba%2C+Barbara&rft.date=2012-05-01&rft.issn=1029-8428&rft.eissn=1476-3524&rft.volume=21&rft.issue=4&rft.spage=379&rft.epage=392&rft_id=info:doi/10.1007%2Fs12640-011-9293-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s12640_011_9293_4 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1029-8428&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1029-8428&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1029-8428&client=summon |